제14회 대한다발성경화증학회 학술대회
일시: 2018-08-18 장소: The K Hotel 별관 2층 금강홀, 3층 동강홀1. Multiple sclerosis (MS)
변소영(국립경찰병원)2. Neuromyelitis optica (NMO)
석흥열(계명의대)3. Human lymphocyte repertories analysis with next generation sequencing technology
정준호(서울의대, 항체공학과)4. Overview
김우준(가톨릭의대)5. Case-based learning I:Anti-MOG disease
김성민(서울의대)6. Case-based learning II:Systemic autoimmune disease
김선영(울산의대)7. Case-based learning III:Neoplastic and lymphoproliferative diseases
이혜림(고려의대)8. European and American new guidelines for MS treatment: how can the guidelines be adapted to clinical practice in Korea?
김수현(국립암센터)9. Kim MJ, Jeun SS, et al.(2017). “Effective combination of methylprednisolone and interferon β-secreting mesenchymal stem cells in a model of multiple sclerosis.”. J Neuroimmunol. 2018 Jan 15;314:81-88.
전신수(가톨릭의대, 신경외과)10. Baek SH, Kim JS, et al.(2018). “Low body mass index can be associated with the risk and poor outcomes of neuromyelitis optica with aquaporin-4 immunoglobulin G in women.” J Neurol Neurosurg Psychiatry. 2018 Jan 25.
백설희(고려의대)11. Hyun JW, Huh SY, et al.(2018). “Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis.”. Mult Scler. 2018 Mar 7.
현재원(국립암센터)12. Seok JM, Choi MS , et al.(2017) “Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life.” PLoS One. 2017 May 23;12(5).
석진명(성균관의대)